购物车
您的购物车当前为空
DOTA-cyclo(RGDfK) 是一种和DOTA类螯合剂多肽,由多肽交联剂DOTA和环状多肽RGDFK构成二聚体,优先靶向肿瘤细胞膜上表达的αvβ3整合素受体,可制备放射性核素偶联物(RDC)并用于癌症诊断和治疗。
DOTA-cyclo(RGDfK) 是一种和DOTA类螯合剂多肽,由多肽交联剂DOTA和环状多肽RGDFK构成二聚体,优先靶向肿瘤细胞膜上表达的αvβ3整合素受体,可制备放射性核素偶联物(RDC)并用于癌症诊断和治疗。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 899 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | DOTA-cyclo(RGDfK) is a and DOTA-like chelator peptide consisting of a dimer of the peptide cross-linker DOTA and the cyclic peptide RGDFK, which preferentially targets the αvβ3 integrin receptor expressed on tumor cell membranes, allowing for the preparation of radionuclide coupled compounds (RDCs) and their use in cancer diagnostics and therapy. |
| 分子量 | 990.07 |
| 分子式 | C43H67N13O14 |
| CAS No. | 909024-55-1 |
| Smiles | C([C@@H]1C(=O)N[C@@H](CCCCNC(CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N1)C3=CC=CC=C3 |
| 密度 | no data available |
| Sequence | {DOTA}-Arg-Gly-Asp-{d-Phe}-Lys |
| Sequence Short | {DOTA}-RGD-{d-Phe}-K |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice. 实际储存温度请以COA为准 | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20 mg/mL (20.2 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多